Troluce Capital Advisors LLC
Source: SEC Form 13F · as of Mar 2026Troluce Capital Advisors LLC holds 3 biotech & pharma companies tracked by BioSniper, totaling $37.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
3
Total value held
$37.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Stoke Therapeutics, Inc. (STOK)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| STOKStoke Therapeutics, Inc. | 652,800 | $21.3M |
| GHRSGH Research PLC | 990,472 | $13.9M |
| IMTXImmatics N.V. | 250,000 | $2.5M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.